October 16, 2026Stocks·Bullish·regulatory
Viatris' RYZUMVI (phentolamine ophthalmic solution) receives FDA approval to treat presbyopia in adults
Viatris received FDA approval for RYZUMVI (phentolamine ophthalmic solution 0.75%) to treat presbyopia in adults.
Detected & updated continuously · Source: Nebula
Story subjects
Opus Genetics, Inc.Food and Drug Administration